Eversana, Amazon Web Service Partner to Accelerate Artificial Intelligence Across Life Sciences Industry
Collaboration aims to help pharmaceuticals drive efficiencies and business value.
In association with Amazon Web Services (AWS), Eversana revealed plans to fast-track the use of artificial intelligence (AI) in the life sciences sector. Through this association, the organizations plan on implementing the technology to help pharmaceutical and life science manufacturers drive efficiencies and business value while improving patient outcomes.
Combining Eversana’s capabilities in AI with AWS’s Amazon Bedrock AI applications, the teams will work to identify, develop, and deploy high-impact solutions across the pharmaceutical commercialization value chain. According to a company press release, planned applications include:
- Medical and regulatory review process solutions, to help optimize time-consuming, manual compliance operations.
- Field and patient assistance solutions, like chatbots, to automate mundane tasks, provide more accurate responses and improve user experiences.
- Disease and product education content generation and personalization services, to help life sciences brands improve engagement with and education for both HCPs and patients.
"We believe we are at an inflection point in the life sciences industry with the rising influence of AI to transform capabilities and reimagine everything from customer experiences and omnichannel engagement to software development and operating models," said Jim Lang, CEO, Eversana, in the company release. "Companies that find the optimal balance of human and AI-powered services will leap ahead in every industry, and pharma is no different. Together with AWS, our goal is to bring AI across the life sciences industry or 'pharmatize it,' shaping the future of digital transformation, driving value for our clients and making a remarkable difference in the lives of patients."
Reference: EVERSANA & Amazon Web Services to "Pharmatize" Artificial Intelligence across the Life Sciences Industry. PR Newswire. July 24, 2023. Accessed July 24, 2023. https://www.prnewswire.com/news-releases/eversana--amazon-web-services-to-pharmatize-artificial-intelligence-across-the-life-sciences-industry-301883377.html
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
